BrainsWay Ltd. (BWAY)

BrainsWay Ltd. (BWAY) is a healthcare company (medical devices) based in Israel. The share price is $9.19, down 2.13% on the day, which values the company at $369.92M. Price as of 17 Nov 2026, 17:28 UTC, from Yahoo Finance.

Key facts

Share price
$9.19−2.13% today
Market value
$369.92M
P/E ratio
38.3×last 12 months
Forward P/E
18.4×
Funk Score
69/100
Against its own history
Well above its usual priceusual price $4.31
200-week average
$6.1150% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

BrainsWay Ltd. in more detail

BWAY trades at 38.3× its last twelve months' earnings, 18.4× next year's expected earnings, 6.1× sales. Measured against its own history, the price is 113% above what its usual multiples would imply ($4.31) — well above its usual price. It sits 50% above its 200-week average of $6.11.

Its Funk Score is 69 out of 100 (financial strength 7.2, profitability 7.6, growth 10.0, value 2.7, each out of 10).

In its favour: Altman Z in the safe zone; Operating margin is expanding. Worth checking: Beneish M-score flags the accounts; Thin interest cover.

1 of the superinvestors tracked here hold BWAY, including Cathie Wood (0.0% of the portfolio).

Superinvestors holding BWAY

1 of the investors tracked here report a position in their latest 13F filing.

BrainsWay Ltd. (BWAY): questions and answers

What is BWAY's P/E ratio?

BrainsWay Ltd. trades at 38.3× its last twelve months' earnings and 18.4× next year's expected earnings.

What is BrainsWay Ltd.'s market cap?

BrainsWay Ltd. is valued at $369.92M at a share price of $9.19.

Is BWAY overvalued or undervalued?

Against its own history, BWAY is well above its usual price: the price is 113% above the $4.31 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is BWAY above its 200-week moving average?

Yes. BWAY is 50.3% above its 200-week average of $6.11. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is BrainsWay Ltd. growing?

Over the last three fiscal years BrainsWay Ltd.'s revenue grew 24.3% a year.

Does BWAY pay a dividend?

BrainsWay Ltd. does not currently pay a regular dividend.

Cite this page

Funkfolio, “BrainsWay Ltd. (BWAY) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/BWAY

Underlying data: Yahoo Finance; company filings with the SEC.